Gunter von Minckwitz, MD, of the University of Frankfurt, offers his thoughts on abstract S3-04, "The phase III ICE study: Adjuvant ibandronate with or without capecitabine in elderly patients with moderate or high risk early breast cancer."
Ann H. Partridge, MD, MPH, of Dana-Farber Cancer Institute, on abstract S3-09, “...
Harry D. Bear, MD, PhD, of Massey Cancer Center, discusses abstract OT1-3-02, “...
Prudence Francis, MD, of Peter MacCallum Cancer Centre, and Hope Rugo, MD, of the University of California, San Francisco, discuss data from abstract S3-08,
Edith A. Perez, MD, of the Mayo Clinic Cancer Center, discusses abstract S1-06,
Lisa A. Carey, MD, of the UNC Lineberger Comprehensive Cancer Center, addresses further analysis of data from abstract S4-05,